Butyric Acid

Butyric Acid

SCHEMBL4153848

CCCC(=O)O.CS(=O)(=O)c1cccc(-c2ccc3[nH]c(=O)c4[nH]ccc4c3c2)c1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FASN P49327 1/20 0.41
CAMKK2 Q96RR4 2/20 0.39
PDPK1 O15530 1/20 0.38
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2A Q12879 1/20 0.37
GRIN2B Q13224 1/20 0.37
GRIN2C Q14957 1/20 0.37
GRIN3A Q8TCU5 1/20 0.37
PTGS2 P35354 7/20 0.36
GRK6 P43250 1/20 0.36
F7 P08709 1/20 0.36
GSK3A P49840 1/20 0.36
GSK3B P49841 1/20 0.36
RXFP1 Q9HBX9 1/20 0.35
TTK P33981 1/20 0.35
SCD O00767 1/20 0.35
NR1H2 P55055 1/20 0.35
NR1H3 Q13133 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4155344 0.94 FASN (0.42) FASNCAMKK2PDPK1GRIN2DGRIN3B
SCHEMBL4715466 0.90 FASN (0.45) FASNCAMKK2PDPK1PTGS2TTK
3-Methylbutanoic Acid SCHEMBL4163003 0.89 FASN (0.40) FASNCAMKK2PDPK1GRIN2DGRIN3B
Propionic Acid SCHEMBL4155190 0.86 PTGS2 (0.40) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL4159560 0.84 VCP (0.41) FASNCAMKK2PDPK1PTGS2
Propionic Acid SCHEMBL4153840 0.82 PIM1 (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Propionic Acid SCHEMBL4159324 0.81 FASN (0.48) FASNCAMKK2GRIN1GRK6F7
Propionic Acid SCHEMBL4161893 0.80 BRD4 (0.43) GSK3B
Propionic Acid SCHEMBL4166173 0.79 GRIN2D (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Propionic Acid SCHEMBL4157983 0.79 BRD4 (0.37) PTGS2F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 FASN 2527/4885CAMKK2 43/4885PDPK1 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.